SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004539
Filing Date
2024-02-01
Accepted
2024-02-01 06:02:11
Documents
19
Period of Report
2024-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48782
2 ex4-01.htm EX-4.01 133742
3 ex4-02.htm EX-4.02 130682
4 ex10-01.htm EX-10.01 51869
5 ex99-01.htm EX-99.01 14861
6 ex99-01_001.jpg GRAPHIC 8988
  Complete submission text file 0001493152-24-004539.txt   641811

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE pali-20240201.xsd EX-101.SCH 3024
8 XBRL LABEL FILE pali-20240201_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE pali-20240201_pre.xml EX-101.PRE 22365
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3662
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 24584901
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)